Learn more and register

As Eli Lilly continues to expand its manufacturing footprint to meet growing patient demand, a reliable yet flexible quality control (QC) laboratory model is crucial. In a session at the ISPE Annual Meeting, project leaders from Lilly and Flad will discuss an effective QC lab model that Lilly has implemented across several sites. The presentation will cover many of the current trends and requirements driving planning and design of QC labs at large-scale pharma and biomanufacturing facilities today.

Topics will include effectively incorporating advanced technology such as automation, digitalization, and AI while planning for future growth and evolving space needs. As technology enables improved efficiency and regulatory compliance, the role of human oversight remains essential. The presentation will also detail the importance of designing facilities with a human-centric approach to support employee well-being. Additionally, the presenters will explore how to maintain a global connection with planning and delivery across sites with different requirements, as well as the advantages and challenges of parallel implementation versus a phased approach.